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Despite the growing use of 18-fluoro-2-deoxyglucose positron emission tomography (18F-
FDG PET)  texture analysis to measure intratumoural heterogeneity in cancer research, the 
biologic basis of 18F-FDG PET-derived texture variables (TV) is poorly understood. We 
aimed to assess correlations between 18F-FDG PET-derived TVs and whole-slide image 
(WSI)-derived metrics of tumour cellularity and spatial heterogeneity. 
Methods  
Twenty-two patients with non-small cell lung cancer (NSCLC) prospectively underwent 
18F-FDG PET imaging before tumour resection. We tested 9 18F-FDG PET parameters: 
metabolically active tumour volume (MATV), total lesion glycolysis (TLG), mean 
standardised uptake value (SUVmean), first-order entropy, energy, skewness, kurtosis, 
grey-level co-occurrence matrix entropy, and lacunarity (SUV-lacunarity). From the 
haematoxylin and eosin-stained WSIs, we derived mean tumour-cell density (MCD) and 
lacunarity (Path-lacunarity). Spearman’s correlation analysis and agglomerative 
hierarchical clustering were performed to assess variable associations. 
Results 
Tumour volumes ranged from 2.2-74 cm3 (median 17.9 cm3). MCD correlated positively 
with TLG (rs: 0.46, p-value: 0.007) and SUVmean (rs: 0.55; p-value: 0.008) and negatively 
with skewness and kurtosis (rs: -0.47 for both; p-value: 0.028 and 0.026, respectively). 
SUV-lacunarity and Path-lacunarity were positively correlated (rs: 0.5; p-value: 0.018). On 
cluster analysis, larger tumours trended towards higher SUVmean and entropy with a 
predominance of tightly concentrated high SUV-voxels (negative skewness and low 
kurtosis on histogram); on WSI-analysis such larger tumours also displayed generally 





Our data suggest that histopathological MCD and lacunarity are associated with several 
commonly used 18F-FDG PET-derived indices including SUV-lacunarity, MATV, SUVmean, 
entropy, skewness, and kurtosis, and thus may explain biological basis of 18F-FDG PET-











18-fluoro-2-deoxyglucose positron emission tomography (18F-FDG PET) derived texture 
variables (TVs) are emerging as potentially useful biomarkers in cancer research. They 
quantify metabolic heterogeneity in different scales of space and direction and there is 
growing evidence supporting the role of TVs in making non-invasive inferences in varied 
oncologic applications, including tumour phenotyping and genotyping, response to 
treatment, and survival prognostication [1–4].  However, beyond the over-expression of 
glucose membrane receptors (e.g. GLUT-1) and upregulation of hexokinase activity in 
cancer cells, our understanding of the biological basis that can be inferred from 
histopathology that influences the spatial and intensity distribution of 18F-FDG PET images 
is lacking and largely conjectural[5]. 
Tumour cell density and spatial heterogeneity on haematoxylin and eosin (H&E) 
microscopy are logical targets for studies seeking associations with 18F-FDG PET imaging, 
since glycolysis is a cellular function and proliferating tumour cells are typically driven by 
anaerobic metabolism [6]. The clinical and experimental observation of low uptake of 18F-
FDG (measured by standardised uptake values, SUVs) in areas of low tumour cellularity 
supports this hypothesis [7,8]. To explore associations between tumour cell density and 
spatial variation with 18F-FDG PET metrics, suitable corresponding whole-slide image-
derived (WSI) metrics are required. Tumour cell density is difficult to estimate from WSIs 
because manual counting is impractical whereas subjective estimates are prone to error [9–
11]. Secondly, a voxel-to-pixel match for TVs, derived from 18F-FDG PET images with 
TVs derived from WSIs, may be limited in its ability to uncover true correlations due to the 
difference in scale between the two modalities and the presence of other influencing factors 
such as differences in glucose transporter (GLUT) expression [12]. Hence, simple, intuitive, 
and objective metrics of tissue heterogeneity need to be developed for comparison with 18F-
FDG PET-derived TVs.   
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Automated tumour cell counting, if done with acceptable error, is a practical alternative to 
subjective estimation, that could be applied to large samples of WSIs. Similarly, lacunarity 
- an intuitive metric of gaps in a geometric structure - can be applied to entire WSIs or 18F-
FDG PET volumes by simply converting them into binary maps representing areas of high 
versus low cellularity (or metabolic activity in case of 18F-FDG PET images) [13,14].  
We hypothesised that tumour cell density and lacunarity measured from WSIs are 
correlated with 18F-FDG PET lacunarity and possibly other commonly reported TVs. The 
objectives of this proof-of-concept study were to develop algorithms to quantify mean 
tumour-cell density (MCD) and lacunarity from WSIs, to enable comparison with 18F-FDG 
PET-derived lacunarity and other TVs.  
 
Materials and Methods 
Patients 
Informed written consent was obtained from all patients in this institutional review board 
approved prospective study. The study population comprised 22 patients with NSCLC. 
Inclusion criteria were: a) Histopathologic diagnosis of NSCLC, b) 18F-FDG PET/CT scans 
performed at our institution within 6 weeks before surgery c) Upfront surgery of the 
primary lung tumour. Patients were excluded if they had tumours smaller than 3 cm, since 
it has been shown 18F-FDG PET/CT texture parameters are strongly influence by tumour 
volume (rather than tumour heterogeneity) in smaller lesions [3]. Twenty-two patients 
(mean age: 65.1 years; 8 men, 14 women) were thus included. Nineteen patients had 
adenocarcinoma (ADCA) and 3 had squamous cell carcinoma (SCCA). Clinical stages 
were: stage IA (n=5), stage IB (n=7), stage IIA (n=1), stage IIB (n=2), stage IIIA (n=6), and 





Patients underwent 18F-FDG PET/CT scans at a median 7 days before surgery (range 1 to 
42 days). 18F-FDG PET/CT scans were acquired on a standardised protocol on a Discovery 
710 scanner (GE Healthcare, Chicago, US). Following a 6-hour fasting period, patients 
were injected with 350-400 MBq 18F-FDG intravenously. As per department protocol, 18F-
FDG PET images were acquired from the base of the skull to the upper thighs 90 minutes 
after tracer injection. Volumetric image reconstruction was performed using the ordered 
subset expectation maximisation algorithm (2 iterations, 24 subsets, with post-construction 
smoothing filter of 4mm), slice thickness of 3.27 mm, and pixel size of 4.7mm. All 
corrections for scatter, randoms, dead time, and decay were applied as standard on the 
scanner. Attenuation correction was obtained with low dose un-enhanced CT (140 kVp and 
65 mAs).  
  
18F-FDG PET-derived heterogeneity parameters  
Reconstructed 18F-FDG PET Digital Imaging and Communications in Medicine (DICOM) 
volumes were imported into in-house image texture-analysis software developed in 
MATLAB (Release 2013b, The MathWorks, Inc., Natick, Massachusetts, United States). A 
semi-automated tumour volume of interest (VOI) delineation workflow was adopted, 
employing an in-house implementation of the three-class fuzzy locally adaptive Bayesian 
(FLAB) segmentation algorithm [15]. First, a VOI was drawn manually by U.B (radiologist 
with 9 years’ experience) around the tumour taking care to exclude metabolically active 
adjacent structures (e.g., myocardium, hilar lymph nodes) and to include at least 2-3mm 
rim of background. This VOI was then processed with FLAB to classify all voxels into 3 
classes, i.e., tumour, background, and region of partial volume averaging. Voxels belonging 
to background class were discarded. A 64-bin quantisation scheme was used since it has 
been shown adequate to characterise typically encountered SUV ranges [16]. We tested 
4 
 
nine parameters: five first-order texture parameters (SUVmean, first-order entropy, energy, 
skewness, and kurtosis), two tumour size-related parameters (metabolically active tumour 
volume [MATV] and total lesion glycolysis [TLG]), one second-order parameter, i.e., grey-
level co-occurrence matrix [GLCM] entropy, and one model-based texture parameter, i.e., 
fractal dimension lacunarity (SUV-lacunarity). The justification to include these parameters 
in this study is as follows: SUVmean, MATV, and TLG are related to tumour metabolism 
and volume, and are used widely in the clinic and research. Compared with SUVmax, whose 
value depends only on a single voxel, or SUVpeak (or the lean body mass corrected SULpeak), 
whose value depends on a small 1cm3 volume, SUVmean provides a more global estimate of 
tumour metabolism and is considered less prone to noise [17]. The first-order texture 
parameters characterise the global intensity distribution through histogram shape. Broadly 
speaking, the mean localises the position of the histogram peak, whereas skewness and 
kurtosis describe histogram symmetry and relative proportions of extreme values, 
respectively [16,18]. Compared with most regional and local parameters, first-order 
parameters have been shown to be highly reproducible in inter-observer and moderately-to-
highly reproducible in inter-scan settings [16,18]. Most importantly, all included features 
besides SUV-lacunarity have been shown in recent studies to be potential biomarkers of 
tumour histopathology, treatment response and patient survival [2,19–22]. Lacunarity is a 
parameter that can be used to quantify the presence of gaps in a structure; the larger the 
gaps the higher the lacunarity [23].  We used lacunarity on the premise that large cell-poor 
regions (i.e., high WSI-derived lacunarity [Path-lacunarity]) would appear as large low-
uptake cold spots on 18F-FDG PET images (i.e., high SUV-lacunarity), contributing to 
image heterogeneity and lowering SUVmean. Relevant details of the texture parameters can 
be found in online supplementary resource 1. 
 
Histopathology slide staining and post-processing 
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Haematoxylin & eosin (H&E) staining was performed on 3-micron thick tissue sections 
fixed in 10% buffered formalin for 24 hours and embedded in paraffin. For H&E staining, 
paraffin-embedded tissue sections were stained manually by a technician using Gill No.3 
Haematoxylin Solution (Sigma-AldrichGHS316). All slides were scanned at 20X 
magnification using a Hamamatsu Nanozoomer digital slide scanner (Hamamatsu 
Photonics K.K., Shizuoka, Japan). Low magnification (0.4 – 0.7X) views covering the 
entire tumour in a single frame (1920 x 1080 pixels) were exported into ImageJ v1.51d 
(National Institutes of Health, Maryland, USA) as Tag Image File Format files [24]. The 
tumour regions were delineated freehand by O.F (year-4 pathology trainee) for further 
processing. The segmented tumors were colour deconvolved into haematoxylin-only 
images (H-images) to allow identification of tumour nuclei [25].  
We analysed the low magnification H-images to quantify tumour heterogeneity on the basis 
of spatial variation in nuclear density. Using the k-mean clustering algorithm, we first 
generated a nuclear density map (N-map) from an entire WSI (one per case) at low 
magnification. The N-map was a three-tone image with pixels denoting tissue categorised 
as “cell-poor”, “tumour-cell rich”, and “immune-cell rich”, in order of increasing nuclear 
density (Fig. 1). From the N-map, the relative weight of each tissue class was computed by 
dividing the number of pixels occupied by the particular class with total number of pixels 
occupied by the whole tumour.  
We derived Path-lacunarity by converting each N-map into a binary image of high versus 
low nuclear-density regions and then using the gliding-box algorithm implemented in 
MATLAB [14].  
To compute MCD, we implemented a cell-counting workflow as follows: First, we 
exported a 1920 x 1080 pixel image of a random 20X HPF view into ImageJ.  After colour-
deconvolution, we used manual thresholding to subtract background. Next, we used the 
built-in watershed algorithm to separate any overlapping nuclei. Considering each particle 
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on the resulting image as a single cell nucleus, we used the built-in ImageJ particle counter 
to count all particles in the image. This procedure was repeated on 20 random sites per WSI 
and the resulting cell counts were multiplied by the tissue weights derived from 
corresponding N-maps to obtain MCD. The total sampled area per slide was thus 
approximately 10.36 mm2 (2.76% of the total area covered by a 25x15mm slide; conversion 
factor: 0.5 micron per pixel at 20X magnification)  [26]. We validated the cell-counting 
workflow using five independent 20X high-power field (HPF) views (total 16431 nuclei) 
annotated manually by a pathologist (OW). Its median error in nuclear count per HPF was 
20.36% [range 6.9% - 35%].   
 
Statistical analysis 
Tumour size, volume, and maximum diameter were reported as medians with ranges. Based 
on N-maps, relative proportions of immune-cell predominant, tumour-cell predominant, 
and cell-poor predominant regions of the WSIs were reported as medians with ranges. 
Examination of variable histograms and scatterplots of variable interactions showed that the 
assumptions of Pearson correlation, i.e., normal distribution of variables, linear 
relationships, and homoscedasticity, were not met [27] . Hence, Spearman rank correlation 
coefficient (rs) was measured to study the relationships among all 18F-FDG PET derived 
and histopathology-derived parameters. Statistical significance was set at a p-value of 
<0.05 in this exploratory analysis [28]. To identify groups of correlated variables, 
agglomerative hierarchical clustering was done using 1-rs as a dissimilarity metric. R 





Measured from 18F-FDG PET images, tumour volumes ranged from 2.2-75 cm3 (median 
17.9 cm3) and diameters ranged from 1.6 cm to 5.2 cm (median 3.4 cm). The immune-cell 
predominant proportion ranged from 0.9% to 16.6% (median: 5.4%), the tumour-cell 
predominant proportion ranged from 15.1% to 55.4% (median: 40.1%), and cell-poor tissue 
ranged from 33.9% to 84.8% (median: 55.1%).   
On correlation analysis, MCD correlated positively with TLG (rs: 0.46, p-value: 0.007) and 
SUVmean (rs: 0.55; p-value: 0.008) and negatively with skewness and kurtosis (rs: -0.47 for 
both; p-value: 0.028 and 0.026 respectively). SUV-lacunarity and Path-lacunarity were also 
positively correlated (rs: 0.5; p-value: 0.018). All correlations are summarised in Fig. 2. 
Cluster analysis revealed two groupings of variables which we labelled Group A and Group 
B (Fig. 3). 
 Variables within each group were positively correlated among themselves and negatively 
with variables belonging to the other group. For example, tumors with large MATV (Group 
A variable) had higher values for other Group A variables and thus showed greater tumour 
cell-rich proportion (MATV/tumour-rich proportion rs: 0.53 ; p-value: 0.01), higher MCD 
(MATV/  rs: 0.26; p-value: 0.236), higher SUVmean (MATV/SUVmean rs: 0.18; p-value: 
0.43), and higher entropy (MATV/GLCM-entropy rs: 0.17; p-value: 0.46). Simultaneously, 
larger tumors showed lower values of Group B variables, i.e., negative skewness and low 
kurtosis (MATV/SUV skewness rs:-0.49; p-value: 0.02, MATV/SUV kurtosis rs: -0.38; p-
value: 0.083). Since Path-lacunarity and SUV-lacunarity were Group B variables, larger 
tumours also generally had low lacunarity (MATV/SUV-lacunarity rs: -0.77; p-value: 
<0.0001; MATV/Path-lacunarity rs: -0.15; p-value: 0.5). Interpreted intuitively, these 
findings suggest that larger tumours had a wider spread of 18F-FDG PET voxel intensities 
as indicated by histogram-derived entropy, kurtosis, and skewness, and had higher tumour 
cell-rich proportions. Although the spread of voxel intensities was larger and hence there 
was greater voxel-to-voxel variability in metabolism, these variations were spread out and 
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did not coalesce into large gaps in metabolic activity (or tumour cellularity on WSI) and 
thus lacunarity remained low. An example of each of a large tumour with high Group 
A/low Group B variables and a small tumour with low Group A/high Group B variables is 
shown in Fig.4  and Fig. 5. 
 
Discussion 
We developed a reproducible workflow with freely available software to quantify nuclear 
density from H&E WSIs. Using H&E stain accumulation on WSI images, we grouped 
tumour regions into tumour-cell rich, immune-cell-rich, and cell-poor regions. This 
grouping allowed us to sample tumour pathological MCD from entire WSIs, and also to 
compute a novel two-dimensional representation of tissue-level heterogeneity as a WSI-
derived analogue of 18F-FDG PET lacunarity.  In our proof-of-concept study, we thus 
showed that it is possible to compare 18F-FDG PET TVs with WSI-derived metrics of 
tumour cell density and spatial heterogeneity. The group-wise correlations we have 
described should enable future studies using 18F-FDG PET TVs to explain some of the 
results on a biological basis. 
We found that MCD correlated positively with TLG (rs: 0.46, p-value: 0.007) and SUVmean 
(rs: 0.55; p-value: 0.008) and negatively with skewness and kurtosis (rs: -0.47 for both; p-
value: 0.028 and 0.026, respectively). SUV-lacunarity and Path-lacunarity were also 
correlated (rs: 0.5; p-value: 0.018). Considering further indirect associations among 18F-
FDG PET-derived and WSI-derived variables allowed us to conjecture two metabolic 
patterns in our dataset. 
Comparing vastly different modalities such as 18F-FDG PET and H&E microscopy, is 
challenging due to difference in scale (resolution of a 18F-FDG PET image is 4-5 mm and 
that of a 20X magnified WSI is 0.5 micron) and cost of large data processing (a single WSI 
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can contain up to 1 GB of data)[26]. Furthermore, whereas 18F-FDG PET images are 
conventionally quantised for texture analysis, quantising large WSI to allow conventional 
texture analysis would require considerable post-processing and, in our opinion, may lose 
variable-to-variable match. Hence we chose a simpler workflow to analyse heterogeneity in 
WSIs that did not involve quantisation of pixel values but binary assignment to zeros or 
ones for cell-poor regions and highly cellular regions respectively. A positive resulting 
correlation between SUV- and Path-lacunarity and between MCD and various 18F-FDG 
PET-derived variables supports our proof-of-concept workflow.  
There are very few previous studies comparing tumour cellularity with 18F-FDG PET 
derived texture features, with comparatively more studies comparing tumour cellularity 
with global metabolism indices such as SUVmean and SUVmax. Most reports support the 
logical relationship between tumour cellularity and 18F-FDG PET metabolism, as found in 
our study, with a few exceptions that we mention here [8,30–35]. In a bid to identify 
biologic explanation of 18F-FDG PET-derived texture variables, Orlhac et al. compared 
texture indices derived from 28 co-registered images obtained from 18F-FDG PET scans, 
autoradiography scans, and histopathologic sections of 3 rats bearing mammary tumours 
[12]. The authors did not find significant correlations between texture indices derived from 
18F-FDG PET images and those derived from histopathologic images, and attributed the 
lack of correlation to differential expression of GLUTs in tissue regions of similar cell 
density. Since our workflow was not based on co-registration of WSIs and 18F-FDG PET 
images but on global trends in TVs based on MCD derived from WSI-samples, we believe 
our workflow allows greater flexibility in local differences between 18F-FDG PET images 
and WSIs. Higashi et al. compared SUVmean with manual tumour cell-counts and GLUT-I 
staining, among other variables [36]. They found a positive correlation between tumour 
cellularity and 18F-FDG PET conditional upon strong GLUT-I staining, concluding that 
GLUT-I expression was the main predictor of 18F-FDG PET activity. While GLUT 
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expression is an important factor modulating tissue sensitivity to 18F-FDG PET uptake, the 
commonly observed fall of 18F-FDG PET as a function of decreasing cell density with 
chemotherapy strongly supports tumour cell density as the primary variable in this 
relationship. Nonetheless, multivariate modelling of 18F-FDG PET metabolism with H&E 
and immunohistochemical parameters including GLUT-I would be a refinement of our 
proof-of-concept design. 
We found two groupings of 18F-FDG PET-histopathologic variables using cluster analysis. 
The variable inter-relationships can be summarised using MATV as the primary variable: 
large tumours had greater MCD, high SUVmean, and a predominance of high-SUV voxel 
with fewer outliers (low skewness and kurtosis). Such tumours also had low SUV-
lacunarity compared to smaller tumours, suggesting less clustering of low-SUV voxels on 
18F-FDG PET images and of cell-poor tissue on WSIs. To our knowledge, there are no in-
vivo studies comparing 18F-FDG PET tumour-volumes with quantitative cell densities. 
However, the positive correlation between MATV, SUVmean,  and GLCM-entropy found in 
our study has been reported previously [21].   
Our study has potential limitations: our cell-counting algorithm counted both benign and 
malignant cells. The presence of stromal cells in MCD estimation would have theoretically 
lowered its correlation with SUVmean proportional to the amount of stromal cells present, 
since stromal cells are less metabolically active than proliferating tumour cells [6]. We also 
acknowledge that MCD is not the only factor influencing 18F-FDG PET activity in a tissue; 
variables such as tumour differentiation and expression of GLUT proteins would also 
influence 18F-FDG PET activity and could be added in future implementations. Finally, 
since we did not co-register 18F-FDG PET and WSIs, we did not correlate derived 
parameters on a voxel-to-pixel basis. However, we believe that the large difference in 
resolution between in-vivo 18F-FDG PET imaging and WSI may make such comparisons 





We observed an association between mean tumour cell density and several 18F-FDG PET 
derived metabolic indices, particularly MATV, SUVmean , skewness, and kurtosis. We also 
found lacunarity, a quantifier of gaps in geometry, to be correlated on 18F-FDG PET 
imaging and WSIs; thus it may be a suitable variable for inter-modality comparison. Our 
results suggest the feasibility of comparing TVs derived from 18F-FDG PET images with 
variables quantified from WSIs.  Future studies could provide a more accurate 
understanding of TVs by including further tissue-variables, e.g., GLUT expression, and 
employing computationally intensive tumour-cell segmentation algorithms. 
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Table 1  
Variable Value* 
Clinical variables  
Age   68.4 years (55.1-87 years) 
Tumour sub-type  
 Adenocarcinoma 19 
 Squamous cell carcinoma 3 
Sex M:F 8:14 
Tumour stage  
 IA 5 
 IB 7 
 IIA 1 
 IIB 2 
 IIIA 6 
 IIIB 1 
  
18F-FDG PET  variables  
SUVmean  7.2 
Tumour diameter 3.4cm (1.6cm - 5.2cm) 
MATV 17.9 cm3 (2.2cm3-75cm3) 
  
WSI variables  
MCD 3500 (640-5457) 
Path-lacunarity  4.1 (1.6-7.2) 
*For continuous variables, median values are provided, with ranges given in between 






Fig.1 Illustrating key steps in our MCD and Path-lacunarity computation workflow. The 
original H&E image (a) is colour-deconvolved to yield the haematoxylin-only H-image (b). 
On the H-image (b), regions with greater haematoxylin clustering indicate high cell-density 
regions. Representative pixels of various tissue-types, i.e., immune-cell predominant, 
cancer-cell predominant, and cell-poor are marked with symbols (cross, square, and circle 
respectively). N-Map (c) is derived after running a 3-class k-means clustering algorithm 
after selecting representative pixels of each tissue type. (d) Path-lacunarity is computed 
from the N-map by re-coding all the high cellularity regions (red and blue regions in (c)) as 
‘1’ and low cellularity regions (green regions in (c)) as ‘0’. 
Fig. 2 (a) Correlation matrix of the measured variables: Positive correlations are shown in 
blue and negative in red, with darker shade implying stronger correlation, as shown in 
colour-key provided. The histogram displayed inside the colour-key shows frequencies of 
different rs values from -1 to +1. (b) Chart of p-values corresponding to the correlation 
matrix in (a). P-values <0.05 are highlighted in colour. *values labeled ‘0’ are <0.0001. 
Fig. 3 (a) Heatmap with each row representing an individual variable and each row, a 
patient. Variables (rows) are grouped and ordered by the strength of correlation among 
them using agglomerative hierarchical clustering. Highly correlated variables exhibit 
similar changes in colour from patient to patient (for example, GLCM entropy and SUV 
entropy) (b) A dendrogram based on cluster analysis shows two groupings of variables 
(blue and red). The lengths of branches between correlated clusters increase with increasing 
dissimilarity between clusters. All connected variables to the right of the vertical dashed 
line have statistically significant rs values. Clustering supporting our hypothesis includes 
the grouping of MCD with SUVmean and with MATV and PET-TLG, and grouping of 
SUV-lacunarity with Path-lacunarity 
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Fig. 4 A prototypical example of a large, highly metabolically active ADCA in an 80-year 
old man (Case 16 on heatmap shown in Fig. 3a). (a) 18F-FDG PET/CT axial section through 
the lungs shows the large 18F-FDG-avid tumour. Specific values of several relevant 
variables are shown in the inset. (b)H-image shows dense tumour/immune cell population 
corresponding to the high SUVmean and negative skew of the 18F-FDG PET image. (c) 
Binary image illustrates low Path-lacunarity (2.8) as smaller sized black regions of low 
cellularity between white regions of high cellularity. 
Fig. 5 A prototypical example of a small tumour in a 64-year old woman with ADCA (Case 
2 on heatmap shown in Fig. 3a). This tumour is at the opposite end of the spectrum to the 
previous example. (a)18F-FDG PET/CT axial image through the lungs exhibits a very low 
activity tumour that has the majority of its voxels displaying SUV values nearer the 
minimum (hence the positive skew). (b) H-image and (c) binary image show large black 
regions of low cellularity separating the white regions of high cellularity. Quantitatively, 
these gaps are represented by the high Path-lacunarity (4.7). 
 
 
 
 
